United States · FDA National Drug Code directory
Eslicarbazepine acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-431_35c91221-dff8-9144-e063-6394a90a57fb
- Product NDC
- 31722-431
- Form
- TABLET
- Composition / generic term
- Eslicarbazepine acetate
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230803
- Source listing expiry
- 20261231
Source-listed ingredients
- ESLICARBAZEPINE ACETATE — 800 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (31722-431-30) · 31722-431-30
- 10 BLISTER PACK in 1 CARTON (31722-431-32) / 10 TABLET in 1 BLISTER PACK (31722-431-31) · 31722-431-32
- 90 TABLET in 1 BOTTLE (31722-431-90) · 31722-431-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →